Nrx

Developer of therapeutics for COVID-19 and neurological disorders

placeWilmington, Delaware, United States calendar_todayFounded 2017 groups22 employees language nrxpharma.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon